<DOC>
	<DOC>NCT02956447</DOC>
	<brief_summary>The goal of this project is to explore the use of exogenous pulsatile kisspeptin as a therapeutic alternative for patients with hyperprolactinemia who are intolerant to current therapies.</brief_summary>
	<brief_title>Administration of Kisspeptin in Patients With Hyperprolactinemia</brief_title>
	<detailed_description />
	<mesh_term>Hypogonadism</mesh_term>
	<mesh_term>Hyperprolactinemia</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>Inclusion/ Confirmed diagnosis by elevated levels of prolactin measured via blood test and MRI imaging confirming no pituitary abnormality or a microprolactinoma (&lt;10 mm). Patients with a macroprolactinoma will be excluded. no history of a medication reaction requiring emergency medical care, no illicit drug use, no excessive alcohol consumption (&lt;10 drinks/week), not currently seeking fertility, breastfeeding or pregnant Physical Examination: normal blood pressure, (systolic BP &lt; 140 mm Hg, diastolic &lt; 90 mm Hg). Laboratory Studies: white blood cell, platelet counts, and TSH between 90% of the lower limit and 110% of the upper limit of the reference range, hemoglobin no less than 0.5 gm/dL below the lower limit of the reference range for normal women, BUN, creatinine, AST, ALT not elevated, negative serum human chorionic gonadotropin (hCG) pregnancy test at the time of screening (additional urine pregnancy test will be conducted prior to drug administration).</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Kisspeptin</keyword>
	<keyword>Hyperprolactinemia</keyword>
</DOC>